Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193805-20-000627
Filing Date
2020-05-22
Accepted
2020-05-22 17:16:41
Documents
5

Document Format Files

Seq Description Document Type Size
1 e619657_s3a-at.htm S-3/A 141618
2 e619657_ex5-1.htm EX-5.1 9141
3 e619657_ex23-1.htm EX-23.1 2238
4 GRAPHIC image_001.jpg GRAPHIC 4073
5 GRAPHIC image_002.jpg GRAPHIC 3896
  Complete submission text file 0001193805-20-000627.txt   165263
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-235475 | Film No.: 20907074
SIC: 2834 Pharmaceutical Preparations